Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on August 14, 2025, reports on the Second Quarter of 2025 for Cellebrite DI Ltd., a foreign private issuer headquartered in Petah Tikva, Israel. The filing primarily serves to distribute a press release announcing second-quarter financial results and a significant leadership change.
Key Financial Metrics
The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are detailed in the attached press release (Exhibit 99.1), which is incorporated by reference into the registrant's registration statements on Form S-8 and Form F-3. The filing text does not provide a clear value for any specific financial figure.
Material Changes
- Leadership Change: Thomas E. Hogan has been named Chief Executive Officer (CEO).
- Financial Results: Second-quarter 2025 results were announced, though specific comparative data versus the prior period is not included in the cover text.
Guidance, Outlook, and Risks
The filing text does not provide specific details regarding future guidance, management commentary on outlook, risks, contingencies, or unusual items. These disclosures are contained within the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2025 revenue, net income, and cash flow figures.
- Verify the effective date and transition plan for Thomas E. Hogan's appointment as CEO.
- Check the referenced Form S-8 and Form F-3 filings for the full GAAP financial tables incorporated by reference.
- Confirm if the press release includes updated forward-looking guidance or risk factors.